NorthRock Partners LLC Sells 492 Shares of HCA Healthcare, Inc. (NYSE:HCA)

NorthRock Partners LLC lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 42.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 655 shares of the company’s stock after selling 492 shares during the quarter. NorthRock Partners LLC’s holdings in HCA Healthcare were worth $266,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. CreativeOne Wealth LLC bought a new stake in shares of HCA Healthcare in the first quarter worth $231,000. Bessemer Group Inc. increased its holdings in HCA Healthcare by 51.2% during the first quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock worth $2,543,000 after buying an additional 2,584 shares during the last quarter. Empowered Funds LLC increased its holdings in HCA Healthcare by 54.3% during the first quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock worth $4,639,000 after buying an additional 4,893 shares during the last quarter. Swedbank AB acquired a new position in shares of HCA Healthcare in the first quarter valued at $95,882,000. Finally, EP Wealth Advisors LLC increased its holdings in shares of HCA Healthcare by 1.6% in the second quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company’s stock valued at $72,335,000 after purchasing an additional 3,516 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on the stock. KeyCorp decreased their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Royal Bank of Canada boosted their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price for the company. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Finally, Truist Financial boosted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Five equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $379.39.

HCA Healthcare Stock Down 5.0 %

HCA stock opened at $348.50 on Thursday. The firm has a 50-day moving average price of $391.18 and a 200-day moving average price of $355.72. HCA Healthcare, Inc. has a 12 month low of $226.48 and a 12 month high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The stock has a market capitalization of $88.28 billion, a P/E ratio of 15.65, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.76%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.70% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.